Sensors small enough to be placed in
patients’ medications are being tested as a means to provide digital feedback
about patient adherence to drug-taking regimens. This new technology will be
pilot tested in China for treating TB.
About the size of a salt grain, the
sensor is activated when it gets wet from stomach juices, completing a circuit
that generates a tiny voltage. The sensor has no battery or antenna. Digital
data from the sensor, recorded by a skin patch worn on the torso, can be sent
to a phone or computer. The data can then be viewed on a computer network by
patients, caregivers, and physicians. The technology, devised by Redwood City,
Calif.-based Proteus Digital Health Inc., was approved last month by the Food
and Drug Administration.
“Overall, people only take their
medications half of the time ... adherence is a really big issue across all
treatments,” said Eric Topol, chief academic officer of Scripps Health, a
nonprofit medical service provider.
Proteus has partnered with the Bill
& Melinda Gates Foundation and China’s Center for Disease Control to test
the technology for TB treatment. With the help of a $560,000 Gates Foundation
grant, Proteus will test the sensors in Chinese TB patients. Treatment for TB
can have unpleasant side effects, leading some patients to drop out of
treatment and place others at risk.
Health experts question whether
patients will accept the monitoring system. “People may not want to wear the
patch and have the medications because they might feel like big brother is
watching,” Topol conceded.
“The point of this technology is not
to say you are being a bad patient. The point is to have accurate data,” said
George Savage, Proteus’ chief medical officer and co-founder.
The Friends of AIDS Foundation is
dedicated to enhancing the quality of life for HIV positive individuals and
empowering people to make healthy choices to prevent the spread of the HIV
virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!